Review: taking Robaxin and Methotrexate together


Summary

Drug interactions are reported among people who take Robaxin and Methotrexate together. This review analyzes the effectiveness and drug interactions between Robaxin and Methotrexate. It is created by eHealthMe based on reports of 339 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Robaxin

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. (latest outcomes from Robaxin 4,268 users)

Methotrexate

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. (latest outcomes from Methotrexate 205,731 users)

On Sep, 15, 2016

339 people who take Robaxin, Methotrexate are studied.


Number of reports submitted per year:

Robaxin and Methotrexate drug interactions.

Drug effectiveness over time:

Robaxin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Methotrexate:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Robaxin:
  • female: 25.0% - (1 of 4 people)
  • male: 0.0% - (0 of 0 people)
Methotrexate:
  • female: 0.0% - (0 of 4 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Robaxin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)
Methotrexate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • joint swelling
  • arthralgia
  • acid reflux
  • migraine
  • nausea
  • anxiety
  • basal cell carcinoma
  • fatigue
  • influenza like illness
  • injection site erythema
1 - 6 months:
  • arthralgia
  • injection site pain
  • joint swelling
  • cervical spinal stenosis
  • chronic obstructive airways disease
  • diabetes mellitus non-insulin-dependent
  • drug intolerance
  • dyspnoea
  • fatigue
  • gastrointestinal disorder
6 - 12 months:
  • psychotic disorder
  • headache
  • acid reflux
  • alopecia
  • back pain
  • barrett's esophagus
  • degenerative joint disease
  • dry eyes
  • dvt
  • edema - peripheral, peripheral edema
1 - 2 years:
  • bronchitis chronic
  • diffuse alveolar damage
  • dyspnoea
  • emphysema
  • haematuria
  • acid reflux
  • back pain
  • barrett's esophagus
  • degenerative joint disease
  • dry eyes
5 - 10 years:
  • injection site pain
  • joint stiffness
  • joint swelling
  • liver disorder
  • local swelling
  • arthralgia
  • blood glucose increased
  • dizziness
  • feeling abnormal
  • hyperhidrosis
10+ years:
  • blood creatinine increased
  • blood pressure immeasurable
  • pulse pressure decreased
  • renal failure
  • white blood cell count decreased
not specified:
  • arthralgia
  • drug ineffective
  • pain
  • headache
  • injection site pain
  • pain in extremity
  • fatigue
  • back pain
  • fall
  • pyrexia

Most common drug interactions by gender *:

female:
  • arthralgia
  • drug ineffective
  • pain
  • headache
  • injection site pain
  • fatigue
  • pain in extremity
  • back pain
  • rheumatoid arthritis
  • fall
male:
  • dyspnoea
  • pain
  • bronchitis chronic
  • diffuse alveolar damage
  • emphysema
  • haematuria
  • psoriatic arthropathy
  • acute respiratory failure
  • arthralgia
  • injection site pain

Most common drug interactions by age *:

10-19:
  • hepatitis c virus test positive
  • abscess jaw
  • amnesia
  • anaemia
  • anxiety
  • arteriosclerosis coronary artery
  • ascites
  • back pain
  • bone cyst
  • bone disorder
20-29:
  • nausea
  • abdominal discomfort
  • abdominal pain
  • abdominal pain upper
  • biliary dyskinesia
  • cholecystitis chronic
  • cholesterosis
  • deep vein thrombosis
  • diarrhoea
  • faeces discoloured
30-39:
  • dizziness
  • pyelonephritis
  • acid reflux
  • arthralgia
  • back pain
  • crohn's disease
  • deep vein thrombosis
  • drug abuser
  • drug dependence
  • drug ineffective
40-49:
  • pain
  • headache
  • diarrhoea
  • arthralgia
  • dizziness
  • rheumatoid arthritis
  • gait disturbance
  • local swelling
  • injection site pain
  • serum procollagen type iii n-terminal propeptide increased
50-59:
  • arthralgia
  • drug ineffective
  • pain
  • headache
  • joint swelling
  • injection site pain
  • pain in extremity
  • asthma
  • fatigue
  • rheumatoid arthritis
60+:
  • arthralgia
  • fatigue
  • drug ineffective
  • injection site pain
  • headache
  • dyspnoea
  • back pain
  • fall
  • pain in extremity
  • psychotic disorder

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Robaxin and Methotrexate?

Can you answer these questions?

More questions for: Robaxin, Methotrexate

You may be interested in these reviews

More reviews for: Robaxin, Methotrexate

On eHealthMe, Robaxin (methocarbamol) is often used to treat muscle spasms. Methotrexate (methotrexate sodium) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.